CAS编号 | 中文名 | 英文名 | 分子式 | 分子量 | 熔点 | 沸点 |
1620278-72-9 | 1-(4-(氨基甲基)苄基)-2-丁基-1H-咪唑并[4,5-c]喹啉-4-胺二盐酸盐 | 1-(4-(Aminomethyl) benzyl)-2-butyl-1h-imidazo [4,5-c]quinoline-4-amine dihydrochloride | C22H27Cl2N5 | 432.39 | | |
1620280-47-8 | 甲基(5-氧代戊基)氨基甲酸叔丁酯 | tert-Butyl methyl(5-oxopentyl)carbamate | C11H21NO3 | 215.29 | | |
1620285-48-4 | (R)-3,3'-双[[[(1R,2R)-2-(异吲哚-2-基)-1,2-二苯乙基]亚氨基]甲基]-1,1'-二-2-萘酚 | (R)-3,3'-bis[[[(1R,2R)-2-(isoindolin-2-yl)-1,2-diphenylethyl]imino]methyl]-1,1'-bi-2-naphthol | C66H54N4O2 | 935.180 | | |
1620293-23-3 | | benzo[b]thiophen-6-amine hcl | | | | |
16203-97-7 | | 1,8,9-anthracenetriol, triacetate | | | | |
162030-42-4 | | 1,4-benzenedicarboxylic acid, di-c11-14-isoalkyl esters, c13-rich | | | | |
1620318-41-3 | 2-(5-(4,4,5,5-四甲基-1,3,2-二氧杂硼杂环戊烷-2-基)噻吩-2-基)乙酸乙酯 | ethyl 2-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)thiophen-2-yl)acetate | C14H21BO4S | 296.19 | | 387.1±32.0 °C(Predicted) |
1620318-88-8 | 2-(5-溴-3-氟吡啶-2-基)乙酸乙酯 | ethyl2-(5-bromo-3-fluoropyridin-2-yl)acetate | C9H9BrFNO2 | 262.08 | | |
1620319-80-3 | (6-(2-甲氧基-2-氧乙基)吡啶-3-基)硼酸 | (6-(2-Methoxy-2-oxoethyl)pyridin-3-yl)boronic acid | C8H10BNO4 | 194.98 | | 358.0±52.0 °C(Predicted) |
1620323-43-4 | 阿比特龙杂质21 | abiraterone impurity 21 | | | | |
1620386-62-0 | 1-(4-甲氧基苯基)-7a-吗啉代-6-(4-硝基苯基)-7-氧代-3a,4,5,6,7,7a-六氢-1h-吡唑并[3,4-c]吡啶-3-羧酸 | ethyl 1-(4-methoxyphenyl)-7a-morpholino-6-(4-nitrophenyl)-7-oxo-3a,4,5,6,7,7a-hexahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxylate | | | | |
162039-22-7 | (3-ethynylcyclobutyl)methanol | | C7H10O | 110.1533 | | |
1620390-43-3 | 3-(5-氨基-3-甲基-1h-吡唑-1-基)苯甲酸盐酸盐 | 3-(5-amino-3-methyl-1h-pyrazol-1-yl)benzoic acid hydrochloride | | | | |
16204-48-1 | 顺-3-苯基环丁烷羧酸 | Rel-(1s,3s)-3-phenylcyclobutane-1-carboxylicacid | C11H12O2 | 176.21 | | |
16204-72-1 | | 2,3-dihydro-1,1,4-trimethyl-1H-indene | C12H16 | 160.26 | | |
1620401-82-2 | | unc0379 | C23H35N5O2 | 413.56 | | |
1620401-83-3 | | unc0379 trifluoroacetate salt | C25H36F3N5O4 | 527.58 | | |
1620408-04-9 | 1,8,13-三羟基三碟烯 | 1,8,13-trihydroxytriptycene | C20H14O3 | 302.33 | | |
1620410-04-9 | | na-boc-ne-azido-d-lysine cyclohexylammonium salt | | | | |
162042-44-6 | L-371257,催产素受体拮抗剂 | L-371257 | C28H33N3O6 | 507.59 | | |
162045-29-6 | | 1-boc-4-[[2-(hydroxymethyl)phenyl]amino]-piperidine | | | | |
162045-30-9 | n-boc-1-(4-哌啶基)-1,2-二氢-4h-3,1-苯并噁嗪-2-酮 | tert-butyl 4-(2-oxo-2,4-dihydro-1h-benzo[d][1,3]oxazin-1-yl)piperidine-1-carboxylate | C18H24N2O4 | 332.39 | | 449.2±45.0 °C(Predicted) |
162045-31-0 | 1-(4-哌啶基)-1,2-二氢-4h-3,1-苯并噁嗪-2-酮盐酸盐 | 1-(4-piperidinyl)-1,2-dihydro-4h-3,1-benzoxazin-2-one hydrochloride | C13H17ClN2O2 | 268.74 | | 398.6°C at 760 mmHg |
162045-40-1 | | 4-([1-(tert-butoxycarbonyl)piperidin-3-yl]methoxy)benzoic acid | | | | |
162045-48-9 | | 1-boc-4-[(2-hydroxyphenyl)amino]piperidine | | | | |
162045-53-6 | 4-(2-氧杂苯并[d]噁唑-3(2h)-基)哌啶-1-甲酸叔丁酯 | tert-butyl 4-(2-oxobenzo[d]oxazol-3(2h)-yl)piperidine-1-carboxylate | C17H22N2O4 | 318.37 | | |
162045-54-7 | 3-(哌啶-4-基)苯并[d]噁唑-2(3h)-酮盐酸盐 | 3-(piperidin-4-yl)benzo[d]oxazol-2(3h)-one hydrochloride | C12H15ClN2O2 | 254.71 | | |
1620451-38-8 | 3-(1-氨基-2-甲氧基-2-氧代乙基)氮杂环丁烷-1-羧酸叔丁酯 | tert-butyl 3-(1-amino-2-methoxy-2-oxoethyl)azetidine-1-carboxylate | C11H20N2O4 | 244.29 | | 315.6±12.0 °C(Predicted) |
1620451-40-2 | 3-(1-(((苄氧基)羰基)氨基)-2-甲氧基-2-氧代乙基)氮杂环丁烷-1-羧酸叔丁酯 | tert-butyl 3-(1-(((benzyloxy)carbonyl)amino)-2-methoxy-2-oxoethyl)azetidine-1-carboxylate | C19H26N2O6 | 378.4195 | | |
1620458-09-4 | Zoliflodacin | | C22H22FN5O7 | 487.44 | | |
162046-50-6 | | 2-(boc-aminomethyl)aniline | C12H18N2O2 | 222.28 | | 382.5°C |
162046-51-7 | 3-甲氧基-4-(甲氧基羰基)苯甲酸 | 3-Methoxy-4-(methoxycarbonyl)benzoic acid | C10H10O5 | 210.18 | | 376.3±27.0 °C(Predicted) |
162046-56-2 | | 4-(1-boc-4-piperidyloxy)benzoic acid | C17H23NO5 | 321.37 | | |
162046-58-4 | 4-(叔丁氧羰氨甲基)环己甲酸 (顺反混合物) | 4-(tert-butoxycarbonylaminomethyl)cyclohexanecarboxylic acid (cis- and trans- mixture) | C13H23NO4 | 257.33 | | |
162046-61-9 | | | C8H4ClF3O2 | 224.56 | | 94℃(15 t |
162046-62-0 | | 3-(chloromethyl)-2-methoxypyridine | C7H8ClNO | 157.60 | | 221.9±25.0 °C(Predicted) |
162046-65-3 | 4-(氯磺酰基)哌嗪-1-羧酸叔丁酯 | tert-butyl4-(chlorosulfonyl)piperazine-1-carboxylate | C9H17ClN2O4S | 284.76 | | |
162046-66-4 | | 4-(4-carboxy-phenyl)-piperazine-1-carboxylic acid tert-butyl ester | C16H22N2O4 | 306.36 | | 476.9°C at 760 mmHg |
1620461-89-3 | | mpeg12-br | C25H51BrO12 | 623.570 | | |
1620466-74-1 | 4-Morpholinoaniline-d8 | | C10H6D8N2O | 186.2 | | |
1620473-17-7 | 三甲基((4-甲基-3-硝基苯基)乙炔基)硅烷 | Trimethyl((4-methyl-3-nitrophenyl)ethynyl)silane | C12H15NO2Si | 233.34 | | |
1620482-22-5 | 苯并[1,2-b:4,5-b']二噻吩-4,8-二基 双(三氟甲磺酸酯) | Benzo[1,2-b:4,5-b']dithiophene-4,8-diyl bis(trifluoromethanesulfonate) | C12H4F6O6S4 | 486.4070 | | |
1620483-21-7 | 1,2,6-三氮杂螺[2.5]辛-1-烯-6-羧酸叔丁酯 | Tert-butyl 1,2,6-triazaspiro[2.5]oct-1-ene-6-carboxylate | C10H17N3O2 | 211.26 | | |
1620486-52-3 | (3R,4R)-1,2,3,4-四氢-1-氧代-3-(3-吡啶基)-2-(2,2,2-三氟乙基)-4-异喹啉羧酸 | (3R,4R)-1,2,3,4-tetrahydro-1-oxo-3-(3-pyridinyl)-2-(2,2,2-trifluoroethyl)-4-isoquinolinecarboxylic acid | | | | |
1620487-87-7 | (e)-1,2-双(1-萘基)-1,2-双(1,1,3,3,5,5,7,7-八乙基-1,2,3,5,6,7-六氢二环戊二烯并苯-4-基)二硅烯 | (e)-1,2-bis(1-naphthyl)-1,2-bis(1,1,3,3,5,5,7,7-octaethyl-1,2,3,5,6,7-hexahydro-s-indacen-4-yl)disilene | C76H104Si2 | 1073.84 | | |
162049-83-4 | 2-((3-三氟甲基)苯基)组胺二马来酸酯 | 2-((3-trifluoromethyl)phenyl)histamine dimaleate | | | | |
16205-32-6 | | 2-fluoroestradiol | | | | |
16205-44-0 | 吡唑并[1,5-α]吡啶-3-甲酸乙酯 | ethyl pyrazolo[1,5-a]pyridine-3-carboxylate | C10H10N2O2 | 190.2 | | 134-135°/2.3mm Hg |
16205-45-1 | 7 -甲基吡唑并[ 1 , 5 - a ] 吡啶-3-羧酸乙酯 | ethyl 7-methylh-pyrazolo[1,5-a]pyridine-3-carboxylate | C11H12N2O2 | 204.23 | 103 °C | |
16205-46-2 | 吡唑并[1,5-a]吡啶-3-甲酸 | pyrazolo[1,5-a]pyridine-3-carboxylic acid | C8H6N2O2 | 162.15 | 199 °C | |